// App-Quantinova.ai

e22102 : Management of pyrexia in metastatic melanoma patients: A real-world clinical experience survey study.

Researchers

Presenter

  • Ambika Satija

Principal Investigators

  • A. Simon Pickard

  • Raluca Ionescu-Ittu

  • Franois Lalibert

  • You-Li Ling

  • Antonio Reis Nakasato

  • Barinder Kang

  • Mei Sheng Duh

  • Jeetvan Patel

Medical Centers

  • Analysis Group, Inc., Boston, MA

  • College of Medicine, University of Illinois at Chicago, Chicago, IL

  • Groupe d'analyse, Ltee, Montreal, QC, Canada

  • Groupe d'analyse, Ltee, Montreal, QC, Canada

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Novartis Pharmaceuticals Corporation, NJ, USA, Rio De Janeiro, Brazil

  • Analysis Group, Inc. and Harvard T. H. Chan School of Public Health, Boston, MA

Locations

  • United States

  • Canada

Companies

  • Analysis Group, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Dabrafenib Mesylate

  • Trametinib

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved